Reborna Biosciences is a biotechnology firm offering research and development of RNA-targeting small molecule drugs for genetic diseases.
Reborna Biosciences has raised $5.3M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in June 2025.
Reborna Biosciences's investors include ICMG Ventures, Mitsubishi UFJ Capital, Nissay Capital, Takeda, UntroD Capital.
Reborna Biosciences is headquartered in Fujisawa, Japan.
Reborna Biosciences is a biotechnology firm offering research and development of RNA-targeting small molecule drugs for genetic diseases.
Reborna Biosciences is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Reborna Biosciences — Funding & Investors." VCBacked, June 25, 2025, https://www.vcbacked.co/company/reborna-biosciences. Accessed September 2, 2026.
VCBacked. (2025). Reborna Biosciences — Funding & Investors. Retrieved September 2, 2026, from https://www.vcbacked.co/company/reborna-biosciences
{{cite web |title=Reborna Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/reborna-biosciences |website=VCBacked |access-date=September 2, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated